Expression and Clinical Relevance of SOX9 in Gastric Cancer

Figure 1

Nuclear expression of SOX9 protein detected by immunohistochemistry (20x magnification). 83% of gastric carcinomas (a and b) express SOX9 in the nucleus. There is a loss of SOX9 expression in 17% of gastric carcinoma cases (c). Nuclear SOX9 expression was also observed in normal gastric mucosa (d).

(a)

(b)

(c)

(d)